Amgen | AMGN - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Coherus Biosciences USD 13.17M 1.69M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Exelixis USD 39.06M 14.91M 2026-06
Genmab DKK 116M 110M 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
J&J USD 9.22B 1.24B 2026-06
Merck USD 3.83B 36M 2026-06
Moderna USD 167M 6M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Takeda JPY 446.78B 44.56B 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06